title: The cholinergic pharmacology of the frog saccule.
abstract: Stimulation of the efferent nerves to the vestibular organs of the frog's inner ear produces either facilitation or inhibition of afferent firing. Similarly, application of acetylcholine (ACH), the major transmitter of the efferents, can produce both facilitation and/or inhibition as previously reported [Guth et al. (1986) Acta Otolaryngol. 102, 194-204; Norris et al. (1988) Hear. Res. 32, 197-206]. The firing rates of afferent neurons of the semicircular canal (SCC) using multiunit recordings are generally facilitated by ACH. Conversely, the firing rates of afferent units innervating the saccule are generally inhibited by ACH. This latter inhibition is antagonized by strychnine more potently than by curare, which is more potent than atropine. When inhibition is antagonized by strychnine or curare an underlying facilitation is revealed. The inhibition of saccular afferents by ACH shows desensitization requiring about 20 min to recover. The ACH-induced inhibition is mimicked by nicotine at very high concentrations but not by dimethyl phenylpiperazinium or cytisine. The fact that multiunit afferent firing from the SCC is generally facilitated while that from the saccule is generally inhibited by ACH suggests a different distribution of ACH receptors and receptor types (i.e. muscarinic or nicotinic and their subtypes) in the two organs and demonstrates the usefulness of recording from multiple units simultaneously. The difference in distribution of ACH receptors may be important for understanding the physiology of vestibular efferents.
authors.affiliation: Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112.
authors.forename: P S
authors.initials: PS
authors.lastname: Guth
authors.forename: A
authors.initials: A
authors.lastname: Dunn
authors.forename: K
authors.initials: K
authors.lastname: Kronomer
authors.forename: C H
authors.initials: CH
authors.lastname: Norris
mesh_terms: D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D003472:Curare / Q000494:pharmacology; D003553:Cystine / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D066298:In Vitro Techniques; D009475:Neurons, Afferent / Q000187:drug effects* / Q000502:physiology; D009538:Nicotine / Q000494:pharmacology; D011894:Rana pipiens; D011950:Receptors, Cholinergic / Q000378:metabolism; D012444:Saccule and Utricle / Q000187:drug effects / Q000294:innervation*; D013331:Strychnine / Q000494:pharmacology; D014018:Tissue Distribution
chemical_list: D011950:Receptors, Cholinergic; D003553:Cystine; D004246:Dimethylphenylpiperazinium Iodide; D009538:Nicotine; D001285:Atropine; D003472:Curare; D013331:Strychnine; D000109:Acetylcholine